Mahendra Bijarnia

Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis

Ludwig Kappos, Matthias Mehling, Rafael Arroyo et al. · Neurology · 2015 · 149 citations

Veterinary Medicine, Immunology, Immunization +16

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study

Ralf Gold, Jacqueline Palace, Arno Siever et al. · Journal of Neurology · 2013 · 126 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Mutagenicity assessment of effluents from textile/dye industries of Sanganer, Jaipur (India): a case study

Nupur Mathur, Pradeep Bhatnagar, Pankaj Nagar et al. · Ecotoxicology and Environmental Safety · 2004 · 109 citations

Pharmacy, Environmental Sciences, Toxicology +16

Mutagenicity evaluation of industrial sludge from common effluent treatment plant

Nupur Mathur, Pradeep Bhatnagar, Krishna Mohan et al. · Chemosphere · 2006 · 54 citations

Engineering, Environmental Engineering, Toxicology +16

Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East

Anat Achiron, Hany Aref, Jihad Inshasi et al. · BMC Neurology · 2017 · 27 citations · Full text

Pharmacy, Internal Medicine, Neurology +13